oving yields. We are committed to inspiring advances in bioprocessing as a trusted partner in the production of critical biologic drugs – including monoclonal antibodies (“mAbs”) and mAb derivatives …
Reciprocal relationship from MASS graph: Reciprocal relationship from RGEN graph: oving yields. We are committed to inspiring advances in bioprocessing as a trusted partner in the production of criti…
uct categories as well as several large companies, including Danaher Corporation (Cytiva), Thermo Fisher Scientific Inc., MilliporeSigma and Sartorius. Many of our competitors are large, well-capital…
Reciprocal relationship from TMO graph: Reciprocal relationship from RGEN graph: uct categories as well as several large companies, including Danaher Corporation (Cytiva), Thermo Fisher Scientific In…
USAspending awards from Department of Defense: $48,742 across 1 awards. HT942524P0046 EQUIPMENT KR2I TFF SYSTEM - KF COMM 2 FOR THE WALTER REED ARMY INSTITTUE OF RESEARCH (WRAIR) | Qwen corrected dir…
USAspending awards from Department of Health and Human Services: $14,372,753 across 1 awards. 75A50121P00074 PHARMACEUTICAL CONSUMABLES EXPANSION AND ACCELERATION: SINGLE USE BAGS, ASSEMBLIES, AND TU…
ernal Control Over Financial Reporting We have audited Repligen Corporation’s internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control—Inte…
Reciprocal relationship from MASS graph: Reciprocal relationship from RGEN graph: ernal Control Over Financial Reporting We have audited Repligen Corporation’s internal control over financial reporti…
uct categories as well as several large companies, including Danaher Corporation (Cytiva), Thermo Fisher Scientific Inc., MilliporeSigma and Sartorius. Many of our competitors are large, well-capital…
Reciprocal relationship from TMO graph: Reciprocal relationship from RGEN graph: uct categories as well as several large companies, including Danaher Corporation (Cytiva), Thermo Fisher Scientific In…
Repligen Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
RGEN-DEBT-12156
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
RGEN-DEBT
Debt stack $687.6M
90%
Market cache reports total debt of $687.6M.
Repligen Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Repligen Corporation.
Repligen Corporation Ownership
Holder
Name
Confidence
Evidence
RGEN-OWNER-BLACKROCK-INC
BlackRock, Inc.
90%
13F overlay lists BlackRock, Inc. as top holder; 446 tracked holders.